Overview

Temocillin Use in Complicated Urinary Tract Infections Due to Extended Spectrum Beta-Lactamases (ESBL)/AmpC Enterobacteriaceae

Status:
Withdrawn

Trial end date:
2012-11-01

Target enrollment:

Participant gender:

Summary

This study is aimed at demonstrating the efficacy of temocillin in the treatment of complicated Urinary Tract Infection (UTI) due to confirmed Extended Spectrum Beta-Lactamases (ESBL) producing or AmpC hyperproducing Enterobacteriaceae in the United Kingdom.

Phase:

Phase 4

Details

Lead Sponsor:

Belpharma s.a.

Treatments:

Penicillins
Temocillin